Delivery Order SPE2DB20D1100-SPE2DB25FE1CJ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count) valued at $1,868.16. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, will be performed at the contractor's Conshohocken, Pennsylvania location. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a Delivery Order valued at $1,940.06 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) on August 12, 2025, with completion scheduled for August 13, 2025. This firm fixed price, non-set-aside contract was performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract executed under a larger Indefinite Delivery Contract vehicle with DLA Troop...
- The Defense Logistics Agency awarded a $4,886.44 delivery order to AmerisourceBergen Drug Corp on June 23, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units). This firm fixed-price contract, which is set to be completed by June 24, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award was made through open competition with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) with a ceiling value of $3,829.24. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 19, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for dextroamphetamine-amphetamine 10 mg capsules (100-count units) with a ceiling value of $1,597.36. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The contract is set to complete by July 22, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) with a contract value of $1,150.92. The award was made on a firm fixed-price basis with no set-aside designation, indicating competitive selection. The place of performance is listed as AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a $1,953.40 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of dextroamphetamine-amphetamine 10 mg capsules (100 count). This firm fixed price contract, which is not set-aside, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The performance location is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a $14,269.44 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count). This is a firm fixed price, non-set-aside contract with a completion date of August 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,393.55 to AmerisourceBergen Drug Corp for the supply of dextroamphetamine-amphetamine 10 mg capsules (100-count) on September 18, 2025, with completion expected by September 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $2,917.12 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of dextroamphetamine-amphetamine 30 mg capsules (100-count units). This firm fixed price delivery order, with an ultimate completion date of September 4, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1CJDelivery Order
The Defense Logistics Agency awarded a $4,713.03 delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of dextroamphetamine-amphetamine 10 mg capsules (100-count). The contract, designated as a firm fixed-price delivery order with no set-aside, has an ultimate completion date of September 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company regularly fulfills delivery orders through open competition for various pharmaceutical products supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. This specific delivery order reflects the company's role in supplying controlled pharmaceutical substances to support military medical supply chain requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 9/25/25 |